Lombard Odier Transatlantic’s Gilead Sciences GILD Stock Holding History

Lombard Odier Transatlantic’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$112K	Buy	1,400 +500	+56%	+$40.6K	0.11%	62
2016 Q2	$75K	Hold	900	–	–	0.08%	70
2016 Q1	$84K	Sell	900 -500	-36%	-$45.1K	0.08%	69
2015 Q4	$141K	Hold	1,400	–	–	0.12%	59
2015 Q3	$136K	Sell	1,400 -500	-26%	-$55.5K	0.14%	50
2015 Q2	$222K	Sell	1,900 -3,800	-67%	-$415K	0.18%	55
2015 Q1	$558K	Hold	5,700	–	–	0.43%	52
2014 Q4	$536K	Buy	+5,700	New	+$590K	0.49%	45

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Lombard Odier Transatlantic's GILD Position: Q3 2016 in Review

Lombard Odier Transatlantic increased its Gilead Sciences (GILD) stake by 56% in Q3 2016, buying an estimated $40.6K and bringing the position to 1,400 shares worth $112K. The position accounts for 0.11% of the portfolio, ranked #62.

Lombard Odier Transatlantic first reported a position in GILD in Q4 2014 and has held it in 8 quarters since. The position peaked at $558K in Q1 2015. 1,558 funds tracked by Wall St. Rank hold GILD as of Q3 2016.

Lombard Odier Transatlantic held 1,400 shares of Gilead Sciences worth $112K as of Q3 2016.
Lombard Odier Transatlantic bought 500 Gilead Sciences shares in Q3 2016, an estimated $40.6K.
Gilead Sciences made up 0.11% of Lombard Odier Transatlantic's portfolio in Q3 2016, its #62 holding.
Lombard Odier Transatlantic first reported a position in Gilead Sciences in Q4 2014 and has held it in 8 quarters since.
Lombard Odier Transatlantic's Gilead Sciences position peaked at $558K in Q1 2015.
1,558 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2016.

Based on Lombard Odier Transatlantic's 13F filing for Q3 2016, filed 14 Nov 2016.